Vaccination
As the nation gears up to celebrate the Fourth of July, healthcare workers across the country are grappling with a resurgence of COVID-19 cases, exacerbated by the spread of the more transmissible Delta variant among the unvaccinated. Despite the progress made in vaccinating over half of Americans over 12, the
Vaccination
Virologist Angela Rasmussen's recent decision to receive a Pfizer-BioNTech coronavirus vaccine booster shot, despite already having received a Johnson & Johnson vaccine, has sparked a debate among experts and raised questions about the need for combined vaccine boosters. Rasmussen's concerns about the emergence of the delta
COVID-19
The global economy continued to send mixed signals as the ongoing COVID-19 pandemic persists, with varying outcomes in different regions. Key takeaways from top news stories this week include Johnson & Johnson's Covid vaccine showing strong immune response against the Delta variant, while Merck & Co's
COVID-19
Vaccine experts have issued a warning about the looming global health challenges posed by the current COVID-19 pandemic and seasonal influenza. New research from the University of North Carolina at Chapel Hill has shed light on the existing strategies for influenza vaccines and how they can inform the development of
Vaccination
Sanofi, a French pharmaceutical giant, has announced a significant investment of EUR2 billion in the mRNA vaccine technology behind pioneering Covid-19 jabs developed by rivals BioNTech, Pfizer, and Moderna. This investment aims to develop at least six vaccine candidates using messenger ribonucleic acid (mRNA) and establish an mRNA "centre
Vaccination
Maine has all but stopped ordering new coronavirus vaccine doses as the number of people seeking first shots has slowed to a crawl. With over 200,000 doses in circulation, the state is working to use up its stockpile as demand plummets. Health officials are struggling to prevent doses from
Coronaviruses
The U.S. House of Representatives Committee on Oversight and Government Reform has launched an expanded investigation into manufacturing problems at Emergent BioSolutions' Bayview facility. Rep. Carolyn B. Maloney and Rep. James E. Clyburn sent letters to the top executives of AstraZeneca and Johnson and Johnson, citing deficient controls
Vaccination
The Betsi Cadwaladr Health Board in Wales has decided to bring forward the second dose interval for the Pfizer vaccine to eight weeks due to the threat posed by the Delta variant of the Covid-19 virus. This change aims to provide stronger protection against the virus, particularly in areas with
Vaccination
Amid the ongoing COVID-19 pandemic, a new surge of infections has hit Indonesia, with over 350 doctors and medical workers contracting the virus despite being vaccinated. In North Korea, leader Kim Jong-un has ordered his government to prepare for both dialogue and confrontation with the United States. Meanwhile, a new
COVID-19
As India grapples with a catastrophic Covid-19 wave, its ambitions to become the "pharmacy of the world" are in tatters. The country's failure to secure enough vaccine shots has led to a de facto export ban, leaving its neighbors, including Nepal, Bangladesh, Bhutan, and Sri Lanka,
Vaccination
Australians under 40 years old without underlying health conditions or high-risk professions are taking advantage of the Covid-19 vaccination program, sparking debate among health experts. Some nurses are encouraging these individuals to get vaccinated, citing the importance of expediting the process. However, Professor Julie Leask from the University of Sydney&
COVID-19
In a recent study published in The Lancet, researchers have found that two doses of the Pfizer-BioNTech vaccine offer 79% protection against the Delta COVID-19 coronavirus variant, while the Oxford-AstraZeneca vaccine provides 60% effectiveness. The study, conducted on 5.4 million people in Scotland, highlights the importance of getting both
